Balance Sheet Data

Biogen Inc. (BIIB)

$221.74

-2.20 (-0.98%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 4,475.902,610.103,802.504,892.801,049.902,580.222,351.282,142.661,952.551,779.30
Total Cash (%)
Account Receivables 1,880.501,913.801,549.402,136.402,1001,501.711,368.471,247.051,136.401,035.57
Account Receivables (%)
Inventories 804.201,068.601,351.501,344.402,527.401,160.871,057.87964.01878.47800.53
Inventories (%)
Accounts Payable 530.80454.90589.20491.50403.30383.11349.12318.15289.92264.19
Accounts Payable (%)
Capital Expenditure -669.50-551.80-294.90-243.20-311.40-304.79-277.74-253.10-230.64-210.18
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.